Arm’s Shift From Royalties to Silicon Manufacturing Could Reshape Chip Economics

Arm’s Shift From Royalties to Silicon Manufacturing Could Reshape Chip Economics

Omor Ibne Ehsan

Mon, September 21, 2026 at 8:33 PM GMT+3 4 min read

Quick Read

• ARM dropped 46% from its June peak; CEO Rene Haas's $2B demand figure finally moved the stock when supply confidence, not the number, changed.

• NVIDIA's Vera CPU feeds Arm's royalties, but Qualcomm's Nuvia license trial in Q4 2026 could reprice royalties across the entire industry.

• Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Arm didn't make the cut. Enter your email to see the names that beat ARM. The report is free. Enter your email and see if any of your stocks made the cut.

Arm (NASDAQ:ARM) stock has moved in three different directions on the same customer-demand figure in four months. The chip designer plunged from an early-September peak near $452 in June to just under $244, a 46% drawdown reflecting a broader unwind of AI capital-spending optimism. On September 18, shares closed at $275.61, up 4.04%, after CEO Rene Haas told Jim Cramer that demand for Arm's technology has "never looked better."

Haas has cited the AGI CPU demand figure before. Arm unveiled the chip in March with a roughly $1 billion revenue guide across fiscal 2027 and 2028. By May, disclosed customer demand had already surpassed that figure, yet the stock fell because the guide did not move. In July, Haas said demand "now exceeds $2 billion." In September, the same $2 billion figure produced the biggest rally yet. The tone changed.

What Actually Changed Between May and September

Supply is what changed. In July, Haas told analysts that "our confidence level and being able to secure the supply necessary has gotten better" across wafers, substrates, test capacity, and memory.

Margins on the in-house silicon are modest by Arm's standards. Child said first-generation gross margin will land in the high 30% range, maybe low 40s, with a longer-term path to 50%. Compare that to Arm's corporate 92.5% gross margin on royalties, and the mix shift is real.

Free Report, Just Released

Why Didn't ARM Make The Top 10 List?

24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.

And ARM didn't make the cut!

The report is free, and you can see why we think each stock is a top investment today.

Enter Your Email and See the Ten →

Where NVIDIA and Qualcomm Sit on the Same Trade

NVIDIA (NASDAQ:NVDA) benefits from this shift. Haas said NVIDIA's Arm-based Vera CPU delivers "up to 50% higher CPU performance and two times greater energy efficiency than comparable x86 systems," feeding Arm's royalty stream.

Qualcomm (NASDAQ:QCOM) sits on both sides. It announced an Arm-based data-center CPU called Dragonfly C1000, yet remains Arm's legal adversary, with the Nuvia license trial expected in Q4 2026. A loss could reprice per-chip royalties across the industry.

Arm trades at a trailing P/E of roughly 326x after a 152.14% year-to-date run. Q1 fiscal 2027 EPS of $0.25 missed the $0.4038 estimate by 38.09%, with operating margin compressed to 7%.

Data-center royalty revenue more than doubled year over year, and Neoverse shipments passed 1.5 billion cores, with the last 500 million arriving in nine months. That is the earnings mix a $294 billion market cap is discounting, and it is the same buildout feeding the power, cooling, and networking names we profiled in a free report on seven AI infrastructure suppliers that aren't chipmakers.

Bull and Bear Case for ARM Stock

The bull case rests on the AGI CPU converting on time. Haas framed the quarter as a "tale of two stories," with Meta as lead partner and NVIDIA, Google Axion, AWS Graviton 5, and Microsoft Cobalt all seeded on Neoverse. If the CPU total addressable market moves toward the $200 billion range Child referenced, current royalty growth understates the runway.

Capacity is the deciding variable. Arm needs first shipments at the end of calendar 2026 to hold this valuation.

Got $1,000? Before You Buy ARM, Read This

If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And ARM wasn't one of them.

They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list -->>

Contact editorial@247wallst.com for any questions or corrections.